About Cleerly
Cleerly is a company based in Denver (United States) founded in 2016 by James Min. Cleerly has raised $578.48 million across 5 funding rounds from investors including Fidelity Investments, Novartis and T. Rowe Price. Cleerly offers products and services including Cleerly Software, Cleerly Plaque Analysis, and Cleerly ISCHEMIA. Cleerly operates in a competitive market with competitors including HeartFlow, Perspectum, Qure.ai, IXICO and Zebra Medical Vision, among others.
- Headquarter Denver, United States
- Founders James Min
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cleerly, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$578.48 M (USD)
in 5 rounds
-
Latest Funding Round
$106 M (USD), Series C
Nov 19, 2024
-
Investors
Fidelity Investments
& 18 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cleerly
Cleerly offers a comprehensive portfolio of products and services, including Cleerly Software, Cleerly Plaque Analysis, and Cleerly ISCHEMIA.
AI tool for analyzing CCTA scans to detect heart disease risks.
Software for assessing arterial plaque to inform treatment strategies.
AI system for identifying ischemia in cardiac imaging.
People of Cleerly
Unlock access to complete
Funding Insights of Cleerly
Cleerly has successfully raised a total of $578.48M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $106 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cleerly
Cleerly has secured backing from 19 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Fidelity Investments, Novartis and T. Rowe Price.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm scaling software and technology companies from early to late stages.
|
Locked | Locked | Locked | |
|
Investments in technology companies are conducted globally by Battery Ventures.
|
Locked | Locked | Locked | |
|
Investment management services are provided focusing on healthcare innovation.
|
Locked | Locked | Locked |
Investor details for Cleerly
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cleerly
Investment portfolio details for Cleerly
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cleerly
Detailed financials for Cleerly
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cleerly Comparisons
Peer comparison for Cleerly
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cleerly
Cleerly operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HeartFlow, Perspectum, Qure.ai, IXICO and Zebra Medical Vision, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiovascular diagnostics are provided using CT scans and analytics.
|
|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
|
| Locked | Locked | Locked |
Provider of AI and SaaS-based medical image based decision support tools
|
|
| Locked | Locked | Locked |
AI-augmented diagnostic tools for radiology imaging are developed.
|
Detailed competitors of Cleerly
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cleerly
Complete news archive for Cleerly
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cleerly
Cleerly was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Cleerly is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
James Min is the current CEO of Cleerly. They have also founded this company.
Cleerly is a funded company, having raised a total of $578.48M across 5 funding rounds to date.
Cleerly was founded in 2016 in Denver, United States, as an AI-based platform for cardiac health assessment. Coronary CT angiograms are analyzed to characterize and quantify atherosclerotic plaque in arteries. Diagnostic capabilities are provided to healthcare providers, enabling identification of risks and support for employee health outcomes. Personalized care options are facilitated within the healthcare sector.
Cleerly's top competitors include Perspectum, Qure.ai and Deeptek.
Cleerly offers Cleerly Software, Cleerly Plaque Analysis, and Cleerly ISCHEMIA.
Cleerly has 19 investors. Key investors include Fidelity Investments, Novartis, T. Rowe Price, New Leaf Venture Partners, and Piper Sandler.